Pharmacologic approaches to cerebral aging and neuroplasticity: insights from the stroke model.

Abstract:

:Brain plasticity is an intrinsic characteristic of the nervous system that allows continuous remodeling of brain functions in pathophysiological conditions. Although normal aging is associated with morphological modifications and decline of cerebral functions, brain plasticity is at least partially preserved in elderly individuals. A growing body of evidence supports the notion that cognitive enrichment and aerobic training induce a dynamic reorganization of higher cerebral functions, thereby helping to maintain operational skills in the elderly and reducing the incidence of dementia. The stroke model clearly shows that spontaneous brain plasticity exists after a lesion, even in old patients, and that it can be modulated through external factors like rehabilitation and drugs. Whether drugs can be used with the aim of modulating the effects of physical training or cognitive stimulation in healthy aged people has not been addressed until now. The risk:benefit ratio will be the key question with regard to the ethical aspect of this challenge. We review in this article the main aspects of human brain plasticity as shown in patients with stroke, the drug modulation of brain plasticity and its consequences on recovery, and finally we address the question of the influence of aging on brain plasticity. :La plasticidad cerebral es una característica intrínseca del sistema nervioso que permite una continua remodelación de las funciones cerebrales en situaciones físiopatológicas. Aunque el envejecimiento normal está asociado con cambios morfológicos y una declinación de las funciones cerebrales, en sujetos de edad avanzada la plasticidad del cerebro se mantiene parcialmente, Cada vez hay mayor evidencia que sustenta la noción que el enriquecimiento cognitivo y el entrenamiento aeróbico inducen una reorganización dinámica de las funciones cerebrales superiores, con lo que ayudan a mantener las habilidades operadonales en el anciano y reducen la incidencia de demencia. Claramente el modelo de accidente cerebro vascular muestra que la plasticidad cerebral espontánea se produce después de la lesión, inclusive en pacientes de edad avanzada y que puede ser modulada a través de factores externos como la rehabilitación y los fármacos, Hasta la fecha no se han identificado fármacos que puedan ser empleados con el objetivo de modular los efectos del entrenamiento físico o de la estimulación cognítiva en ancianos sanos, La relación riesgo:benefícío será la pregunta clave respecto a los aspectos éticos de este desafío. En este artículo se revisan los aspectos principales de la plasticidad cerebral humana como se observa en pacientes con accidentes cerebro vasculares, la modulación por fármacos de la plasticidad neuronal y sus consecuencias en la recuperación, y finalmente se aborda la pregunta acerca de la influencia del envejecimiento en la plasticidad cerebral. :La plasticité cérébrale est une caractéristique propre du système nerveux central qui permet un remodelage permanent de son activité à la fois dans des conditions physiologiques et au cours des maladies neurologiques. Bien que le vieillissement s'accompagne de modifications de structure et d'une diminution des performances cognitives, les capacités de plasticité restent au moins partiellement conservées chez le sujet âgé. Un faisceau d'arguments préclinique et clinique plaide pour un rôle majeur des stimulations cognitives et physiques dans le maintien des fonctions cognitives au cours du vieillissement. Le « modèle » de l'accident vasculaire cérébral démontre clairement que le cerveau âgé est capable de se réorganiser après une lésion unique aiguë et focale et que cette réorganisation peut être modulée par des facteurs externes tels que la rééducation et certains médicaments. On ne sait pas encore si les médicaments sont capables de moduler les effets des stimulations physique et cognitive. Les aspects éthiques et le rapport bénéfice-risque seront au coeur du débat. Nous traitons dans cet article les différents aspects de la plasticité cérébrale que l'accident vasculaire cérébral a permis de décrire, nous envisageons l'action des médicaments sur la plasticité cérébrale post-lésionnelle et la récupération fonctionnelle et nous évoquons l'influence du vieillissement sur les capacités du cerveau humain à se reconfigurer lorsqu'il est lésé.

authors

Chollet F

subject

Has Abstract

pub_date

2013-03-01 00:00:00

pages

67-76

issue

1

eissn

1294-8322

issn

1958-5969

journal_volume

15

pub_type

杂志文章,评审
  • Omics approaches to individual variation: modeling networks and the virtual patient.

    abstract::Every human is unique. We differ in our genomes, environment, behavior, disease history, and past and current medical treatment-a complex catalog of differences that often leads to variations in the way each of us responds to a particular therapy. We argue here that true personalization of drug therapies will rely on ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Lehrach H

    更新日期:2016-09-01 00:00:00

  • Depression and end-of-life care for patients with cancer.

    abstract::Patients with cancer and depression experience more physical symptoms, have poorer quality of life, and are more likely to have suicidal thoughts or a desire for hastened death than are cancer patients who are not depressed. Despite the ubiquity of depressive symptoms in cancer patients at the end of life, critical qu...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Rosenstein DL

    更新日期:2011-01-01 00:00:00

  • Psychosis related to neurological conditions: pro and cons of the dis- / mis-connectivity models of schizophrenia.

    abstract::Schizophrenia is still a condition with obscure causes and psychopathology. This paper aims to discuss the "disconnectivity" hypothesis in relation to some neurological conditions which are known to alter brain connectivity, as well as mimicking some aspects of the disorder. After a short historical introduction to th...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Foucher JR,Luck D

    更新日期:2006-01-01 00:00:00

  • The genetics of obsessive-compulsive disorder: a review.

    abstract::Obsessive-compulsive disorder (OCD) is a serious psychiatric disorder that affects approximately 2% of the populations of children and adults. Family aggregation studies have demonstrated that OCD is familial, and results from twin studies demonstrate that the familiality is due in part to genetic factors. Only three ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Pauls DL

    更新日期:2010-01-01 00:00:00

  • A brief review of the genetics and pharmacogenetics of opioid use disorders.

    abstract::Increased physician prescribing of opioids to treat chronic nonprogressive pain has been accompanied by an increase in opioid addiction. Twin studies of opioid addiction are consistent with an inherited component of risk, approximately 50%. Several genome-wide association study (GWAS) reports indicate that genetic ris...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Berrettini W

    更新日期:2017-09-01 00:00:00

  • Do we need to rethink our current classifications of mental disorders?
.

    abstract::The traditional categorical classification system and new diagnostic systems will be discussed in this issue.
. :Mettre la traduction ES. :Mettre la traduction FR. ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 社论

    doi:10.31887/DCNS.2020.22.1/fthibaut

    authors: Thibaut F

    更新日期:2020-03-01 00:00:00

  • Epilepsy research: a window onto function to and dysfunction of the human brain.

    abstract::As one of the most common neurological disorders, epilepsy has devastating behavioral, social, and occupational consequences and is associated with accumulating brain damage and neurological deficits. Epilepsy comprises a large number of syndromes, which vary greatly with respect to their etiology and clinical feature...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Beck H,Elger CE

    更新日期:2008-01-01 00:00:00

  • Experimental models of stress.

    abstract::Illustrating the complexity of the stress response and its multifaceted manifestations is the leading idea of this overview of experimental paradigms used for stress induction in laboratory animals. The description of key features of models based on naturalistic stressors, pharmacological challenges, and genomic manip...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Patchev VK,Patchev AV

    更新日期:2006-01-01 00:00:00

  • Partial remission, residual symptoms, and relapse in depression.

    abstract::Partial remission from depression, with residual symptoms, is an important problem in depression. This paper reviews the frequency and features of this outcome, and its association with relapse. Residual symptoms occur in many depressed patients after acute treatment. They span the typical symptoms of depression, exce...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Paykel ES

    更新日期:2008-01-01 00:00:00

  • Diagnostic classification of psychiatric disorders and familial-genetic research.

    abstract::The validity of diagnostic definitions in psychiatry is directly related to the extent to which their etiology can be specified. However, since detailed knowledge of causal or susceptibility factors is lacking for most psychiatric disorders with a known or suspected familial-genetic origin, the current widely accepted...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Maier W

    更新日期:1999-12-01 00:00:00

  • Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications.

    abstract::Major depressive disorder (MDD) is a major public health concern. Despite tremendous advances, the pathogenic mechanisms associated with MDD are still unclear. Moreover, a significant number of MDD subjects do not respond to the currently available medication. MicroRNAs (miRNAs) are a class of small noncoding RNAs tha...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Dwivedi Y

    更新日期:2014-03-01 00:00:00

  • Alcoholism: the dissection for endophenotypes.

    abstract::Alcohol dependence (alcoholism) is a complex disorder attributed to the interaction of genetic and environmental factors that form a collage of "disease" predisposition, which is not identical for every alcohol-dependent individual. There is considerable evidence to demonstrate that genetic predisposition accounts for...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Hines LM,Ray L,Hutchison K,Tabakoff B

    更新日期:2005-01-01 00:00:00

  • The evaluation of cognitive function in the dementias: methodological and regulatory considerations.

    abstract::Impairment of cognitive function is the central feature of dementia. Although, clinically, the cognitive deficit most often manifests itself as memory problems, a number of other areas of cognition are affected, and memory is but one of the cognitive skills compromised in dementia. Dementia with Lewy bodies, for examp...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Wesnes KA,Harrison JE

    更新日期:2003-03-01 00:00:00

  • Biological markers for early detection and pharmacological treatment of Alzheimer's disease.

    abstract::The introduction of biological markers in the clinical management of Alzheimer's disease (AD) will not only improve diagnosis relating to early detection of neuropathology with underlying molecular mechanisms, but also provides tools for the assessment of objective treatment benefits. In this review, we identify a num...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Hampel H,Broich K,Hoessler Y,Pantel J

    更新日期:2009-01-01 00:00:00

  • Personalized medicine in psychiatry: ethical challenges and opportunities.

    abstract::Pharmacogenomic developments hold promise for personalized medicine in psychiatry with adjusted therapeutic doses, predictable responses, reduced adverse drug reactions, early diagnosis, and personal health planning. The prospects are exciting, but at the same time, these new techniques stand faced with important scie...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Evers K

    更新日期:2009-01-01 00:00:00

  • Current perspectives in the management of treatment-resistant depression.

    abstract::Depressive disorders are a leading cause of disability worldwide and greatly impact morbidity, health care utilization, and medical costs. Major depression that does not resolve with adequate antidepressant treatment is termed treatment-resistant depression (TRD), There is no universally accepted definition of TRD and...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Parikh RM,Lebowitz BD

    更新日期:2004-03-01 00:00:00

  • SPECT assessment of brain activation induced by caffeine: no effect on areas involved in dependence.

    abstract::Caffeine is not considered addictive, and in animals it does not trigger metabolic increases or dopamine release in brain areas involved in reinforcement and reward. Our objective was to measure caffeine effects on cerebral perfusion in humans using single photon emission computed tomography with a specific focus on a...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Nehlig A,Armspach JP,Namer IJ

    更新日期:2010-01-01 00:00:00

  • Nonpharmacological treatments for anxiety disorders.

    abstract::An evidence-based review of nonpharmacological treatments for anxiety disorders is presented. The vast majority of the controlled research is devoted to cognitive behavior therapy (CBT) and shows its efficiency and effectiveness in all the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Cottraux J

    更新日期:2002-09-01 00:00:00

  • Cannabinoids and their therapeutic applications in mental disorders
.

    abstract::Mental disorders represent a significant public health burden worldwide due to their high prevalence, chronically disabling nature, and substantial impact on quality of life. Despite growing knowledge of the pathological mechanisms that underlie the development of these disorders, a high percentage of patients do not ...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:10.31887/DCNS.2020.22.3/pfadda

    authors: Scherma M,Muntoni AL,Riedel G,Fratta W,Fadda P

    更新日期:2020-09-01 00:00:00

  • Opposite effects of stressful experience on memory formation in males versus females.

    abstract::It has become increasingly clear that males and females differ even more dramatically than we previously thought. Not only do they exhibit differing responses to stress and environmental experience, but they can also respond in opposite directions. In rats, it has been shown that exposure to an acute stressful event c...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Shors TJ

    更新日期:2002-06-01 00:00:00

  • Applications of magnetic resonance imaging for treatment-resistant late-life depression.

    abstract::Late-life depression (LLD) is a growing public and global health concern with diverse clinical manifestations and etiology. This literature review summarizes neuroimaging findings associated with depression in older adults and treatment-response variability. LLD has been associated with cerebral atrophy, diminished my...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Agudelo C,Aizenstein HJ,Karp JF,Reynolds CF 3rd

    更新日期:2015-06-01 00:00:00

  • Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.

    abstract::There is mounting evidence that recurrent mood disorders - once considered "good prognosis diseases"- are, in fact, often very severe and life-threatening illnesses. Furthermore, although mood disorders have traditionally been conceptualized as neurochemical disorders, there is now evidence from a variety of sources d...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Quiroz JA,Manji HK

    更新日期:2002-03-01 00:00:00

  • Core symptoms of major depressive disorder: relevance to diagnosis and treatment.

    abstract::The construct of major depressive disorder makes no etiological assumptions about populations with diverse symptom clusters. "Depressed mood" and "loss of interest or pleasure in nearly all activities" are core features of major depressive episode, though a strong case can be made to pay increasing attention to sympto...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Kennedy SH

    更新日期:2008-01-01 00:00:00

  • Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism.

    abstract::Alcohol dependence is a frequent, chronic, relapsing, and incurable disease with enormous societal costs. Thus, alcoholism therapy and research into its outcome are of major importance for public health. The present article will: (i) give a brief overview of the epidemiology, pathogenesis, and treatment outcomes of al...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 临床试验,杂志文章

    doi:

    authors: Krampe H,Stawicki S,Hoehe MR,Ehrenreich H

    更新日期:2007-01-01 00:00:00

  • Addressing neuropsychiatric disturbances during rehabilitation after traumatic brain injury: current and future methods.

    abstract::Cognitive, emotional, behavioral, and sensorimotor disturbances are the principal clinical manifestations of traumatic brain injury (TBI) throughout the early postinjury period. These post-traumatic neuropsychiatric disturbances present substantial challenges to patients, their families, and clinicians providing their...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Arciniegas DB

    更新日期:2011-01-01 00:00:00

  • Lighting a path: genetic studies pinpoint neurodevelopmental mechanisms in autism and related disorders.

    abstract::In this review, we outline critical molecular processes that have been implicated by discovery of genetic mutations in autism. These mechanisms need to be mapped onto the neurodevelopment step(s) gone awry that may be associated with cause in autism. Molecular mechanisms include: (i) regulation of gene expression; (ii...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Pescosolido MF,Yang U,Sabbagh M,Morrow EM

    更新日期:2012-09-01 00:00:00

  • The epidemiology of anxiety disorders: a review.

    abstract::Epidemiological studies show that anxiety disorders are highly prevalent and an important cause of functional impairment; they constitute the most frequent menial disorders in the community. Phobias are the most common with the highest rates for simple phobia and agoraphobia. Panic disorder (PD) and obsessive-compulsi...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Martin P

    更新日期:2003-09-01 00:00:00

  • Biomarkers in development of psychotropic drugs.

    abstract::Biomarkers have been receiving increasing attention, especially in the field of psychiatry In contrast to the availability of potent therapeutic tools including pharmacotherapy, psychotherapy, and biological therapies, unmet needs remain in terms of onset of action, stability of response, and further improvement of th...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章,评审

    doi:

    authors: Wiedemann K

    更新日期:2011-01-01 00:00:00

  • Treatment mechanisms: traditional and new antipsychotic drugs.

    abstract::The first generation of antipsychotic drugs was discovered in the 1960s and 1970s, These agents were effective in treating psychosis, but were accompanied by significant side effects, including severe parkinsonism and akathisia. Second-generation antipsychotics were introduced in the 1990s, These drugs have at least e...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 杂志文章

    doi:

    authors: Tamminga CA

    更新日期:2000-09-01 00:00:00

  • Pursuit of the "truth" about mental illness: the significance of findings in neuropsychiatric research, and lessons from the past.

    abstract::Technology in genetics and brain imaging has advanced so rapidly that it is difficult to be knowledgeable about all the new tools being used in the pursuit of progress toward understanding and treating mental illness. While findings from new studies remain promising, caution is needed with regard to their current appl...

    journal_title:Dialogues in clinical neuroscience

    pub_type: 社论

    doi:

    authors: DeLisi LE

    更新日期:2014-12-01 00:00:00